Article Information
History
- April 5, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Caroline F. Dalton1,2,*,
- Madalena IR de Oliveira1,3,
- Prachi Stafford1,
- Nicholas Peake1,
- Binita Kane4,
- Andrew Higham4,
- Dave Singh4,5,
- Natalie Jackson5,
- Helen E. Davies6,
- David A. Price7,
- Rae Duncan8,
- Nicola Tattersall1,
- Amanda Barnes9 and
- David P. Smith1,*
- 1Biomolecular Sciences Research Centre, Sheffield Hallam University, Sheffield, U.K.
- 2Advanced Wellbeing Research Centre, Sheffield Hallam University, Sheffield, U.K.
- 3MSD R&D Innovation Centre Ltd, London, U.K.
- 4Division of Immunology, Immunity to Infection and Respiratory Medicine, University of Manchester and Manchester University NHS Foundation Trust, Manchester, UK
- 5Medicines Evaluation Unit, Southmoor Road, Manchester, U.K.
- 6Department of Respiratory Medicine, University Hospital of Wales, Llandough, Penarth, U.K.
- 7Division of Infection and Immunity, Cardiff University School of Medicine, University Hospital of Wales, Cardiff, U.K.
- 8Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, U.K.
- 9Agilent Technologies LDA UK Ltd, Didcot, U.K.
- ↵*Co-corresponding authors c.f.dalton{at}shu.ac.uk, d.p.smith{at}shu.ac.uk
Posted April 05, 2024.
Increased fibrinaloid microclot counts in platelet-poor plasma are associated with Long COVID
